Over 60 Firms Confirmed to Attend CBI's Third Annual Bio/Pharmaceutical Collaboration...

Over 60 Firms Confirmed to Attend CBI's Third Annual Bio/Pharmaceutical
Collaboration and Transaction Accounting Conference in September

BOSTON, Aug. 27 /PRNewswire/ -- The Center for Business Intelligence (CBI), a
division of Advanstar Communications, is pleased to announce their full agenda
for the 3rd Annual Bio/Pharmaceutical Collaboration and Transaction
Accounting. Over 60 firms are already confirmed to gather in Philadelphia on
September 22nd for this one-day seminar to hear expert insights and discuss
industry case examples for accounting for collaborations and transactions.
Perspectives on FASB, IFRS and US GAAP, plus updates on the impact of EITF
07-1, EITF 99-19, EITF 00-21, EITF 07-3 and EITF 08-A will be presented.

The FASB and SEC are considering refinements to the collaboration accounting
model. This, coupled with the trend of IFRS convergence, make it critical that
life science companies master the financial accounting and reporting of
deal-making activities. Amidst changing regulations, top executives from
companies such as Goldman Sachs, FASB, GlaxoSmithKline, Infinity
Pharmaceuticals and Johnson & Johnson will examine:

-- Recent Mergers and Acquisitions Impacting the Pharmaceutical Sector
-- Examples of Exotic Financings in Life Sciences
-- Trends in Deal Values and Economic Factors in Assessing and Valuing
Innovation
-- Milestones and Revenue Arrangements with Multiple Deliverables
-- EITF Updates on Revenue Recognition and Capitalization of Milestone
Payments
-- Considerations from a JFC Perspective for Joint Steering Committees
(JSCs) and Other Joint Collaboration Meetings

-- FASB Accounting Guidelines for Collaborative Arrangements and Revenue
Recognition

If you would like to view the full agenda, please visit this page. A
"best-in-class" reputation, CPE credits and professional networking make this
an extremely worthwhile event. For more information on this event, please
visit http://www.cbinet.com/collaboration. If you would like to apply for a
press pass, please contact Erica Kirwan of CBI at 339.298.2263.

About CBI:

A subsidiary of Advanstar Communications, CBI Research, Inc. offers
Pharmaceutical and Healthcare conferences that serve senior executives and
government officials by providing a unique platform for highly focused content
and ideal networking opportunities with senior policy- and decision-makers.
CBI events provide you with concrete, real-life examples that you can begin to
apply at your organization immediately for significant impact on costs and
revenue. For more information, please visit http://www.cbinet.com.

This release was issued through eReleases(TM). For more information, visit
http://www.ereleases.com.

SOURCE Center for Business Intelligence

Erica Kirwan of CBI, +1-339-298-2263